Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Webinars / 2021 / Advanced structural analysis of risk loci for congenital diaphragmatic hernia using optical genome mapping technology
Bionano Genomics Inside the Lab Technology and innovation Genetics and epigenetics Software and hardware

Advanced structural analysis of risk loci for congenital diaphragmatic hernia using optical genome mapping technology

In this webinar, Dr. Frances High will explore how she used Bionano’s Saphyr system for optical genome mapping to analyze structural variations in a large cohort of patients with CDH and their parents.

03/24/2021 2pm GMT

Share

Available On-Demand

March 24th 7am PST | 2pm GMT

Congenital diaphragmatic hernia (CDH) is one of the most common structural birth defects, occurring in up to one of every 2,500 live births. Although surgical and medical treatment has advanced significantly, survival rates remain at 50 to 80 percent with significant morbidity. To date little is known of the basic molecular mechanisms that underlie CDH.

In this webinar, Dr. Frances High will explore how she used Bionano’s Saphyr system for optical genome mapping to analyze structural variations in a large cohort of patients with CDH and their parents, and how it has led to the identification of critical genes and pathways creating improved understanding of the disorder.

Learning Objectives

  • Understand congenital diaphragmatic hernia and the evidence for a genetic etiology.

  • Review case studies of CDH patients to become familiar with causative structural variants.

  • Compare platforms for assessing structural variation and understand how optical genome mapping can offer improved resolution of some structural variants.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

More Webinars

Diagnostics Genetics and epigenetics

October 25, 2021

Genetic and Transcriptional Contributions to Relapse in Acute Myeloid Leukemia

Subspecialties Software and hardware Microscopy and imaging

Multiplex Immunofluorescence (mIF) 101: The Fundamentals

Inside the Lab Cytology

December 16, 2021

Digital Cytopathology: Is it a curse or a blessing?

False

Advertisement

Recommended

False

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.